Bayer's transformation focuses on a revitalized portfolio, strong pipeline, and strategic operational changes for sustained ...

Bayer is acquiring two investigational molecular imaging agents from Attralus for the diagnosis of cardiac amyloidosis.

“At Bayer, we are committed to harnessing cutting-edge technology to advance regenerative agriculture and enhance productivity,” said Christina Lawrence, Head of Seed Production Innovation at Bayer’s ...

Bayer is successfully executing on an ambitious growth strategyFive pivotal approvals worldwide in 2025 underscore a landmark year of strategic executionBayer will drive significant global regulatory ...

Bayer AG Innovation Procurement and Scientist.com have signed a multi-year extension that elevates Scientist.com to Bayer’s preferred global channel for sourcing external R&D services. “Bayer is ...

New Bayer innovation platform will help organizations build AI-powered apps that assist radiologists, reducing burnout and supporting more efficient diagnoses LAS VEGAS--(BUSINESS WIRE)--Bayer and ...

Bayer to acquire AT-01 & AT-05, investigational molecular imaging agents for the diagnosis of cardiac amyloidosis from Attralus: Berlin, Germany Wednesday, January 14, 2026, 11:00 ...

Shares of German pharma giant Bayer AG BAYRY gained 6.6% on Jan. 14, following an update by partner Orion, a Finnish ...

Bayer has awarded a $1.5 million grant to BioSTL, a nonprofit organization dedicated to fostering growth in St. Louis’ bioscience, innovation and technology community. The grant will help fund ...

The facility’s new space enhances the company’s Consumer Health production capabilities, embraces automation, and invests in workforce development and community engagement Today, Bayer proudly ...

SAN FRANCISCO--(BUSINESS WIRE)--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about change on Earth, today announced an expanded relationship with Bayer through a ...